Medications for Wolffparkinsonwhite Syndrome

33 results

  • betapace

    (sotalol HCl)
    Skyepharma Production SAS
    Betapace/Betapace AF is indicated for treating life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia, and for delaying recurrence of highly symptomatic atrial fibrillation/atrial flutter in patients currently in sinus rhythm. It is not intended for patients with easily reversible paroxysmal atrial fibrillation.

  • flecainide acetate

    (Flecainide)
    Ranbaxy Pharmaceuticals Inc.
    Flecainide is indicated for the prevention of paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. It also treats documented life-threatening ventricular arrhythmias, but it is contraindicated in post-myocardial infarction patients and not recommended for chronic atrial fibrillation.

  • flecainide acetate

    (Flecainide Acetate Tablet)
    Bryant Ranch Prepack
    Flecainide Acetate Tablets USP are indicated for preventing paroxysmal supraventricular tachycardias (PSVT) and paroxysmal atrial fibrillation/flutter (PAF) with disabling symptoms, as well as documented life-threatening sustained ventricular tachycardia. Not recommended for patients with recent myocardial infarction or less severe ventricular arrhythmias.

  • flecainide acetate

    (Flecainide Acetate Tablet)
    Bryant Ranch Prepack
    Flecainide Acetate Tablets USP are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for documented life-threatening sustained ventricular tachycardia. Use is not recommended in patients with recent myocardial infarction or less severe ventricular arrhythmias.

  • flecainide acetate

    (Flecainide Acetate)
    Amneal Pharmaceuticals LLC
    Flecainide is indicated for preventing paroxysmal supraventricular tachycardias (PSVT) and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. It is also used for documented life-threatening ventricular arrhythmias. Its use is contraindicated in patients with recent myocardial infarction and chronic atrial fibrillation is not recommended.

  • flecainide acetate

    (flecainide acetate)
    Bryant Ranch Prepack
    Flecainide Acetate Tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for life-threatening sustained ventricular tachycardia. The drug should not be used in patients with recent myocardial infarction or chronic atrial fibrillation.

  • flecainide acetate

    (flecainide acetate)
    Bryant Ranch Prepack
    Flecainide acetate tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease, as well as life-threatening ventricular arrhythmias. Their use is not recommended for patients with recent myocardial infarction or chronic atrial fibrillation.

  • flecainide acetate

    (Flecainide Acetate)
    A-S Medication Solutions
    Flecainide acetate tablets are indicated for preventing paroxysmal supraventricular tachycardias (PSVT) and paroxysmal atrial fibrillation/flutter (PAF) with disabling symptoms, as well as life-threatening documented ventricular arrhythmias. Use in patients with recent myocardial infarction or chronic atrial fibrillation is not recommended.

  • flecainide acetate

    (Flecainide Acetate)
    Bryant Ranch Prepack
    Flecainide acetate tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They're also used for documented, life-threatening sustained ventricular arrhythmias but should not be used post-myocardial infarction or for chronic atrial fibrillation.

  • lidocaine hci and dextrose

    (LIDOCAINE HCI AND DEXTROSE)
    HF Acquisition Co LLC, DBA HealthFirst
    Lidocaine hydrochloride is indicated for the intravenous treatment of ventricular arrhythmias during cardiac procedures and for life-threatening ventricular arrhythmias, particularly during acute myocardial infarction.